By Mill Chart
Last update: Jan 3, 2024
In this article, we'll take a closer look at DEXCOM INC (NASDAQ:DXCM) as a potential candidate for growth investing. While it's important for investors to conduct their own research, DEXCOM INC has piqued our interest by appearing on our strong growth and breakout radar. Let's explore further.
A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:DXCM has received a 9 out of 10:
A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:DXCM has received a 6 out of 10:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NASDAQ:DXCM has earned a 8 out of 10:
Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NASDAQ:DXCM is 8:
Besides having an excellent technical rating, DXCM also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is very little resistance above the current price.
More Strong Growth stocks can be found in our Strong Growth screener.
Check the latest full fundamental report of DXCM for a complete fundamental analysis.
Our latest full technical report of DXCM contains the most current technical analsysis.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
DEXCOM INC
NASDAQ:DXCM (4/19/2024, 7:00:00 PM)
After market: 129.32 -1.39 (-1.06%)130.71
-3.59 (-2.67%)
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
This April, discover three game-changing tech stocks with disruptive technologies poised to future-proof your portfolio in 2024.
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.
Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments
The Relative Strength (RS) Rating for DexCom stock entered a new percentile Monday, with a rise from 80 to 83.
These healthcare companies' target markets substantially overlap.